People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery. The condition is more common in women and younger patients ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as the world’s first transfemoral transcatheter mitral valve replacement ...

Mitral regurgitation is the most common form of valvular heart disease and affects around 10% of Americans over 75. It occurs when the mitral ...

Mitral annular disjunction, MAD, is a heart abnormality in which the mitral valve attachment 'slides'. In recent years, the condition has been linked to an increased risk of severe cardiac ...

Mitral annular disjunction, MAD, is a heart abnormality in which the mitral valve attachment ‘slides’. In recent years, the condition has been linked to an increased risk of severe cardiac arrhythmias ...

as well as reduced early diastolic mitral annular velocity using tissue Doppler imaging. In late stages with LV failure associated with elevations in left atrial pressure, a so-called restrictive ...

Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...

Edwards Lifesciences Corporation, leading global structural heart innovation company, announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment ...